Cutting edge resources to accelerate innovative research

Scientific advancement depends on a strong foundation of data credibility. However, scientific findings in biomedical research are not always reproducible. Meet the organizations that are promoting best practices and helping researchers perform the highest-quality science.

The complexities associated with metagenomics methods have posed significant challenges toward the standardization of microbiome research applications. Credible reference materials can help identify and normalize sources of assay bias and improve the consistency and reproducibility of data.

Accurate detection methods are essential for reducing the spread of antimicrobial-resistant strains. Clinically relevant isolates with validated susceptibility and genetic data enable precision during diagnostic development.

Gene-editing tools such as CRISPR/Cas9 can be used to create isogenic cell lines, which can be further used to model a specific patient population. An isogenic cell line was created to model cancer patients with the echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) fusion oncogene and tested for its sensitivity to inhibitors of ALK.

Solute carrier kidney transporter (SLC) models are essential for determining the renal clearance of drugs, environmental compounds, and endogenous molecules. Three different hTERT-immortalized human primary renal proximal tubule epithelial cells (RPTEC) were modified and tested for functionality and stable expression of the OAT1, OCT2, and OAT3 proteins.

Neural progenitor cells, CRISPR/Cas9 genome-edited cell lines, and organoids help to create sophisticated models for probing life’s biggest mysteries.

It takes the combined efforts of dedicated scientists to discover the treatments and diagnostic tools needed to keep humankind healthy and safe.

ATCC is taking a stand against the challenges facing credibility in life science research. Join us on our journey.

A webinar about a new line of hTERT-immortalized cells that remain biologically relevant yet plentiful enough for multiple assays.